Nuwellis to exit international operations to accelerate U.S. revenue growth

Nuwellis (NUWE) announced its decision to exit international operations in order to focus exclusively on the U.S. market-where the company is seeing the strongest growth and clinical demand. This strategic realignment supports Nuwellis’ core business strategy: investing in the markets driving revenue growth. With expanding traction in U.S. cardiac surgery and pediatric programs, and a rising opportunity in the hospital-based outpatient space, the company is streamlining to prioritize investment in markets where it can have the most immediate and long-term impact. Cardiac surgery, pediatrics, and outpatient models are emerging as the strongest growth drivers for Nuwellis, offering faster intervention, better patient outcomes, and more efficient resource use. This strategic pivot positions the company to lead in this evolving care landscape. The company will continue to support its international partners through a structured wind-down period. This shift underscores Nuwellis’ broader strategy to align operations with market demand and deliver shareholder value through operational discipline and customer focus.